Jasper Therapeutics (JSPR) Earnings Date & Reports

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

JSPR is expected to report earnings to rise 577.25% to -27 cents per share on August 07

Jasper Therapeutics JSPR Stock Earnings Reports

Q2'26

Est.

$-0.27

Q1'26

Beat

by $0.63

Q4'25

Beat

by $1.78

Q3'25

Beat

by $0.87

Q2'25

Beat

by $0.16

The last earnings report on May 14 showed earnings per share of -3 cents, beating the estimate of -67 cents. With 286.69K shares outstanding, the current market capitalization sits at 12.83M.

View a ticker or compare two or three

Compare

JSPR

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for JSPR